Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
UBS
Cipla
Mallinckrodt
Chinese Patent Office
Cerilliant
Merck
Julphar
Healthtrust

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021744

« Back to Dashboard

NDA 021744 describes PROQUIN XR, which is a drug marketed by Depomed Inc and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the PROQUIN XR profile page.

The generic ingredient in PROQUIN XR is ciprofloxacin hydrochloride. There are thirty-one drug master file entries for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride profile page.
Summary for 021744
Tradename:PROQUIN XR
Applicant:Depomed Inc
Ingredient:ciprofloxacin hydrochloride
Patents:1
Formulation / Manufacturing:see details
Pharmacology for NDA: 021744
Ingredient-typeQuinolones
Suppliers and Packaging for NDA: 021744
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744 NDA Depomed, Inc. 13913-001 E 13913-001-03
PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744 NDA Depomed, Inc. 13913-001 E 13913-001-30

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 500MG BASE
Approval Date:May 19, 2005TE:RLD:No
Patent:➤ Sign UpPatent Expiration:Jun 20, 2020Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 021744

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Depomed Inc PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744-001 May 19, 2005 ➤ Sign Up ➤ Sign Up
Depomed Inc PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744-001 May 19, 2005 ➤ Sign Up ➤ Sign Up
Depomed Inc PROQUIN XR ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 021744-001 May 19, 2005 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Federal Trade Commission
Healthtrust
Dow
Harvard Business School
Covington
US Army
Farmers Insurance
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.